RNLS gene expression was increased in pancreatic ductal adenocarcinoma cell (PDAC) lines with KRAS2 mutations (MiaPaCa2 and Panc1) compared to those with wild type KRAS2, such as BxPC3 (Supplement Fig. 3S). Here, KRAS is linked to pancreatic ductal adenocarcinoma.